Shahram Attarian

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

David Adams, Alejandra González‐Duarte, William O’Riordan et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 587 citations · Full text

Medicine, Generalised Myasthenia Gravis

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden et al. · Journal of the Peripheral Nervous System · 2021 · 461 citations · Full text

European Academy of Neurology/Peripheral Nerve Society guideline on diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint Task Force—Second revision

Peter Van den Bergh, Pieter A. van Doorn, Robert D. M. Hadden et al. · European Journal of Neurology · 2021 · 416 citations · Full text

Regional variation of Guillain-Barré syndrome

Alex Y. Doets, Christine Verboon, Bianca van den Berg et al. · Brain · 2018 · 301 citations · Full text